Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
The American Journal of Cardiology
|
August 31, 1987
Efficacy and safety of intravenous nadolol for supraventricular tachycardia
A Y Olukotun, G J Klein
The American Journal of Cardiology
|
August 31, 1987
Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation
R G Zoble, J Brewington, A Y Olukotun, et al.
The American Journal of Cardiology
|
August 31, 1987
Efficacy and safety of oral nadolol for exercise-induced ventricular arrhythmias
R J Sung, A Y Olukotun, C L Baird, et al.
The American Journal of Cardiology
|
August 31, 1987
Beta blockers in combination with class I antiarrhythmic agents
P C Deedwania, A Y Olukotun, J Kupersmith, et al.
British Heart Journal
|
September 1, 1980
Left ventricular function in Friedreich's ataxia. An echocardiographic study
M G Sutton, A Y Olukotun, A J Tajik, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 1, 1995
Safety of gadoteridol injection: U.S. clinical trial experience
A Y Olukotun, J R Parker, M J Meeks, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1982
Intravenous pirbuterol
C V Leier, S Nelson, P Huss, et al.
The American Journal of Cardiology
|
August 31, 1987
Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting
S F Khuri, O N Okike, M Josa, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 1, 1994
Phase I clinical evaluation of a new iron oxide MR contrast agent
S J McLachlan, M R Morris, M A Lucas, et al.
The American Journal of Cardiology
|
February 1, 1987
Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias
S Saksena, G J Klein, P R Kowey, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
The American Journal of Cardiology
|
August 31, 1987
Efficacy and safety of intravenous nadolol for supraventricular tachycardia
A Y Olukotun, G J Klein
The American Journal of Cardiology
|
August 31, 1987
Comparative effects of nadolol-digoxin combination therapy and digoxin monotherapy for chronic atrial fibrillation
R G Zoble, J Brewington, A Y Olukotun, et al.
The American Journal of Cardiology
|
August 31, 1987
Efficacy and safety of oral nadolol for exercise-induced ventricular arrhythmias
R J Sung, A Y Olukotun, C L Baird, et al.
The American Journal of Cardiology
|
August 31, 1987
Beta blockers in combination with class I antiarrhythmic agents
P C Deedwania, A Y Olukotun, J Kupersmith, et al.
British Heart Journal
|
September 1, 1980
Left ventricular function in Friedreich's ataxia. An echocardiographic study
M G Sutton, A Y Olukotun, A J Tajik, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
January 1, 1995
Safety of gadoteridol injection: U.S. clinical trial experience
A Y Olukotun, J R Parker, M J Meeks, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1982
Intravenous pirbuterol
C V Leier, S Nelson, P Huss, et al.
The American Journal of Cardiology
|
August 31, 1987
Efficacy of nadolol in preventing supraventricular tachycardia after coronary artery bypass grafting
S F Khuri, O N Okike, M Josa, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
May 1, 1994
Phase I clinical evaluation of a new iron oxide MR contrast agent
S J McLachlan, M R Morris, M A Lucas, et al.
The American Journal of Cardiology
|
February 1, 1987
Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias
S Saksena, G J Klein, P R Kowey, et al.
Page
of 2